Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution.
Hedberg J, Studebaker A, Smith L, Chen CY, Westfall JJ, Cam M, Gross A, Hernandez-Aguirre I, Martin A, Kim D, Dhital R, Kim Y, Roberts RD, Cripe TP, Mardis ER, Cassady KA, Leonard J, Miller KE. Hedberg J, et al. Among authors: cripe tp. Mol Ther Oncolytics. 2023 Jul 19;30:39-55. doi: 10.1016/j.omto.2023.07.006. eCollection 2023 Sep 21. Mol Ther Oncolytics. 2023. PMID: 37583388 Free PMC article.
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
Chu Y, Nayyar G, Tian M, Lee DA, Ozkaynak MF, Ayala-Cuesta J, Klose K, Foley K, Mendelowitz AS, Luo W, Liao Y, Ayello J, Behbehani GK, Riddell S, Cripe T, Cairo MS. Chu Y, et al. Mol Ther Oncol. 2024 May 24;32(2):200820. doi: 10.1016/j.omton.2024.200820. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38933492 Free PMC article.
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.
Luo W, Hoang H, Miller KE, Zhu H, Xu S, Mo X, Garfinkle EAR, Costello H, Wijeratne S, Chemnitz W, Gandhi R, Liao Y, Ayello J, Gardenswartz A, Rosenblum JM, Cassady KA, Mardis ER, Lee DA, Cripe TP, Cairo MS. Luo W, et al. Among authors: cripe tp. J Exp Clin Cancer Res. 2024 Jul 11;43(1):193. doi: 10.1186/s13046-024-03093-w. J Exp Clin Cancer Res. 2024. PMID: 38992659 Free PMC article.
Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients.
Upadhyay R, Klamer B, Matsui J, Chakravarthy VB, Scharschmidt T, Yeager N, Setty BA, Cripe TP, Roberts RD, Aldrink JH, Singh R, Raval RR, Palmer JD, Baliga S. Upadhyay R, et al. Among authors: cripe tp. Cancers (Basel). 2024 May 30;16(11):2090. doi: 10.3390/cancers16112090. Cancers (Basel). 2024. PMID: 38893209 Free PMC article.
Reviving the lost art of meeting reports.
Cripe TP. Cripe TP. Mol Ther Oncol. 2024 Mar 8;32(1):200781. doi: 10.1016/j.omton.2024.200781. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596300 Free PMC article. No abstract available.
Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society.
Cripe TP, Roberts RD, Chandler DS, Setty BA, Chen S, Shenoy A, Venkataramany AS, Ringwalt EM, Scharschmidt T, Utset-Ward T, Konieczkowski DJ, Grignol VP, Beane JD, Ruff SM, Pollock RE. Cripe TP, et al. Mol Ther Oncol. 2024 Mar 2;32(1):200779. doi: 10.1016/j.omton.2024.200779. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596308 Free PMC article. No abstract available.
Molecular Therapy Oncology: What's in a name?
Cripe TP. Cripe TP. Mol Ther Oncolytics. 2023 Nov 10;31:100739. doi: 10.1016/j.omto.2023.100739. eCollection 2023 Dec 19. Mol Ther Oncolytics. 2023. PMID: 38155922 Free PMC article. No abstract available.
155 results